PD RX Pharmaceutical (CE) (USOTC:PDRX)
Historical Stock Chart
From Jul 2019 to Jul 2024
![Click Here for more PD RX Pharmaceutical (CE) Charts. Click Here for more PD RX Pharmaceutical (CE) Charts.](/p.php?pid=staticchart&s=NO%5EPDRX&p=8&t=15)
PD-Rx Net Complies With Reporting Requirements of Controlled
Substances in 9 States
OKLAHOMA CITY, March 10 /PRNewswire-FirstCall/ -- PD-Rx Pharmaceuticals, Inc.
(OTC Pink Sheets: PDRX), a publicly held corporation, today announced that it
has completed the software development necessary to comply with nine separate
states' reporting requirements on controlled prescription medications.
A proprietary software program called "PD-Rx Net", will be able to transmit the
transaction history file of all prescribed medications electronically to each
state and their respective law enforcement agency to review for the
prescription drug abuse.
Shawn Stephens, the MIS Director with PD-Rx Pharmaceuticals states, "The new
programming changes to 'PD-Rx Net' will allow each state to monitor drug trends
and patterns of prescription drug abuse. The information collected with the
use of the 'PD-Rx Net System' will be essential in controlling the abuse and
diversion of controlled substances."
When asked about the multi-dimensional state requirements of Pedigrees
documentation, Mr. Stephens stated: "We've actually expanded our staff in order
to quickly innovate, deploy, and meet the emerging requirement of each state to
track the movement of pharmaceutical products throughout the United States."
With the development and use of computer programs like "PD-Rx Net" and the
automation of data collection, each state and its law enforcement agencies will
have the opportunity to monitor drug diversion and crack down on criminals and
other abused substances in the pharmaceutical market.
ABOUT THE COMPANY
PD-Rx offers pharmaceutical and management strategies to the healthcare
industry. Our management strategies focus on new products, solid business
partners, and the specialized segment of the pharmaceutical industry. As a
licensed FDA manufacturer and repackager, PD-Rx offers a full spectrum of
medications and specialized services. Our goal is to develop a matrix of cost
containment tools and products that we can merge into any healthcare network to
enhance patient care and improve managed care organizations bottom line. We
provide proprietary products and prepackaged medications that are viewed by
patient, insurance payers, and healthcare providers as a progressive and
responsive practice.
This press release contains "forward-looking" statements within the meaning of
the Private Securities Litigation Reform Act of 1995. Such forward-looking
statements involve known and unknown risks and uncertainties or other factors,
which may cause actual results, performance or achievements expressed or
implied by such forward-looking statements to vary from those forecast or
implied in this release. Factors that might cause such a difference include,
without limitation, decline in demand for the company's products or services,
and the effect of general economic conditions and factors affecting the
industry.
DATASOURCE: PD-Rx Pharmaceuticals, Inc.
CONTACT: Jack L. McCall, EVP & COO of PD-Rx Pharmaceuticals, Inc.,
+1-405-942-3040